IRIS
BENNETT, DAVID
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.697
NA - Nord America 8.570
AS - Asia 3.747
SA - Sud America 613
Continente sconosciuto - Info sul continente non disponibili 365
AF - Africa 185
OC - Oceania 16
Totale 22.193
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.387
IT - Italia 2.655
RU - Federazione Russa 1.789
GB - Regno Unito 1.329
SG - Singapore 1.127
CN - Cina 1.036
IE - Irlanda 906
BR - Brasile 512
VN - Vietnam 497
DE - Germania 446
SE - Svezia 368
FR - Francia 364
HK - Hong Kong 343
UA - Ucraina 234
FI - Finlandia 222
IN - India 152
BD - Bangladesh 121
KR - Corea 115
CA - Canada 108
ZA - Sudafrica 96
ES - Italia 76
NL - Olanda 63
TR - Turchia 59
PL - Polonia 54
CZ - Repubblica Ceca 46
JP - Giappone 46
IQ - Iraq 42
AR - Argentina 38
MX - Messico 38
AT - Austria 25
CI - Costa d'Avorio 24
BE - Belgio 23
ID - Indonesia 22
UZ - Uzbekistan 22
MA - Marocco 17
IR - Iran 16
NG - Nigeria 16
PH - Filippine 16
AU - Australia 15
EC - Ecuador 15
VE - Venezuela 15
AZ - Azerbaigian 14
AE - Emirati Arabi Uniti 13
CH - Svizzera 13
JO - Giordania 12
PK - Pakistan 12
SA - Arabia Saudita 12
LT - Lituania 11
IL - Israele 10
KE - Kenya 10
MY - Malesia 10
EG - Egitto 9
KZ - Kazakistan 9
GR - Grecia 8
PE - Perù 8
HU - Ungheria 7
JM - Giamaica 7
MK - Macedonia 7
RO - Romania 7
CO - Colombia 6
CR - Costa Rica 6
PT - Portogallo 6
UY - Uruguay 6
BG - Bulgaria 5
BO - Bolivia 5
CY - Cipro 5
DK - Danimarca 5
KG - Kirghizistan 5
PY - Paraguay 5
AL - Albania 4
BY - Bielorussia 4
DZ - Algeria 4
NO - Norvegia 4
TT - Trinidad e Tobago 4
CL - Cile 3
EU - Europa 3
GE - Georgia 3
HR - Croazia 3
LK - Sri Lanka 3
PA - Panama 3
AM - Armenia 2
ET - Etiopia 2
GD - Grenada 2
GT - Guatemala 2
HN - Honduras 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 21.806
Salva come PNG Salva come JPEG
Città #
Dallas 1.418
Southend 1.108
Dublin 890
Singapore 713
Ashburn 637
Fairfield 579
Moscow 526
San Jose 501
Chandler 443
Santa Clara 441
Milan 435
Hong Kong 315
Beijing 289
Siena 284
Woodbridge 254
Council Bluffs 234
Seattle 225
Wilmington 208
Ann Arbor 200
Los Angeles 189
Cambridge 184
Houston 183
Jacksonville 181
Hefei 176
New York 167
Munich 165
Ho Chi Minh City 148
Rome 147
Florence 135
Helsinki 123
Princeton 120
Seoul 113
Lauterbourg 105
Hanoi 96
Johannesburg 87
The Dalles 86
Buffalo 61
Boardman 58
Columbus 57
Chicago 56
Dearborn 54
Nanjing 53
Dong Ket 50
London 49
Turku 47
Orem 45
Shanghai 44
Warsaw 44
Frankfurt am Main 43
Tokyo 43
Fremont 42
Málaga 42
São Paulo 40
Catania 38
San Mateo 37
Nuremberg 36
Chennai 35
Montreal 30
Turin 30
Bengaluru 28
Toronto 28
Da Nang 26
Menlo Park 26
San Diego 26
Atlanta 25
Abidjan 24
Izmir 24
Brno 23
Denver 23
Düsseldorf 23
Washington 23
Brussels 21
Manchester 21
Mumbai 21
Naples 21
Phoenix 21
Bologna 20
Lappeenranta 20
Nanchang 20
San Francisco 20
Boston 19
Brooklyn 19
Figino 19
Guangzhou 19
Olomouc 19
Poplar 19
Redondo Beach 19
Tashkent 19
Baghdad 18
Changsha 18
Lastra a Signa 18
Shenyang 18
Gavirate 17
Paris 17
Abuja 16
Padova 16
Haiphong 15
Messina 15
Amsterdam 14
Brescia 14
Totale 13.971
Salva come PNG Salva come JPEG
Nome #
La chitotriosidasi: un sensibile biomarker di sarcoidosi 1.062
A first update on mapping the human genetic architecture of COVID-19 601
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 440
Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fibrosis, sarcoidosis, systemic sclerosis and pulmonary Langerhans cell histiocytosis 397
An explainable model of host genetic interactions linked to COVID-19 severity 386
Antirheumatic agents in covid-19: is IL-6 the right target? 368
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 367
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 355
Peripheral biomarkers' panel for severe COVID-19 patients 323
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 313
Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers 311
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 302
Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis 291
Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns 284
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 284
Exhaled nitric oxide in interstitial lung diseases 278
Airway-Centered Pleuroparenchymal Fibroelastosis Associated with Non-Necrotizing Granulomas: A Rare New Entity 276
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 275
Idiopathic pulmonary fibrosis a rare disease with severe bone fragility 272
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 264
Diagnosis of idiopathic pulmonary fibrosis by virtual means using “IPFdatabase”- a new software 262
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 260
Prognostic bioindicators in severe COVID-19 patients 258
Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience 256
Posttransplant solid organ malignancies in lung transplant recipients: A single-center experience and review of the literature 255
Serial KL-6 measurements in COVID-19 patients 253
Diffuse panbronchiolitis in a patient with common variable immunodeficiency: a casual association or a pathogenetic correlation? 250
Serum chitotriosidase levels in patients with allergic and non-allergic asthma 246
Rituximab Therapy in Interstitial Lung Disease associated with Rheumatoid Arthritis 246
Serum amyloid A in patients with idiopathic pulmonary fibrosis 246
Bronchial stenosis following lung transplant: An innovative approach with a modified endobronchial emphysema valve 244
Pirfenidone therapy for familial pulmonary fibrosis: a real-life study. 234
Strategies for Maximising Lung Utilisation in Donors After Brain and Cardiac Death: A Narrative Review 233
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 232
Pirfenidone in chronic lung allograft dysfunction: a single cohort study 231
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 231
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 229
Acute exacerbation of idiopathic pulmonary fibrosis after inhalation of a water repellent 228
Chitotriosidase: a sensitive biomarker of sarcoidosis 224
SARS-CoV-2 in pleural fluid in a kidney transplant patient 224
Whole-genome sequencing reveals host factors underlying critical COVID-19 217
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 217
Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence 216
Extracorporeal Photopheresis in Lung Transplantation 216
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 215
WES profiling of COVID-19 215
Oxidative stress in the pathogenesis of diffuse lung diseases: a review 209
Alteration of Immune-checkpoint after specific stimulation with CMV antigens in pre-LTx patients 205
Human Chitotriosidase: a sensitive biomarker of sarcoidosis 204
Controversial role of RAGE in the pathogenesis of idiopathic pulmonary fibrosis 204
Biomarkers in sarcoidosis: The contribution of system biology 202
Proteomic investigation of pulmonary sarcoidosis 201
Impact of SARS-CoV-2 outbreak on heart and lung transplant: a patient-perspective survey 201
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 201
Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution 200
BIOMARKERS WITH CLINICAL SIGNIFICANCE IN PATIENTS WITH INTERSTITIAL LUNG DISEASES 199
IPF mortality in waiting list for lung transplantation 193
Helicobacter pylori antibody positivity in idiopathic pulmonary fibrosis 188
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 186
Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant 186
Mortalità in lista per trapianto di polmone in pazienti affetti da fibrosi polmonare idiopatica 185
Timing of Osteoporotic Vertebral Fractures in Lung and Heart Transplantation: A Longitudinal Study 178
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study 176
Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective 173
Familial pulmonary fibrosis: Clinical-functional and radiological features 171
New concepts in the pathogenesis of sarcoidosis 169
Rischio infettivo nel trapianto di polmone per fibrosi polmonare: analisi retrospettiva 169
Comparative proteomic analysis of bronchoalveolar lavage of familial and sporadic cases of idiopathic pulmonary fibrosis 168
null 165
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction 164
Incidenza e fattori di rischio per colonizzazione ed infezione respiratoria batterica a 30 giorni in pazienti trapiantati di polmone 163
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 161
Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis 161
IPFdatabase - A new tool for a correct application of idiopathic pulmonaty fibrosis guidelines 161
The Role of Galectins in Chronic Lung Allograft Dysfunction 161
Outcome of ECMO bridge to lung transplantation: a single cohort study 159
Cavernous sinus syndrome due to neurosarcoidosis in adolescence: a diagnosis not to be missed 158
Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseases 154
Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study 153
Valutazione dell'ossido nitrico nell'esalato delle polmoniti interstiziali idiopatiche 149
null 145
Assessing Short- and Medium-Term Outcomes of Lung Transplantation in Elderly Recipients: A Comparative Age-Based Analysis 142
Exhaled nitric oxide and carbon monoxide in lung transplanted patients 140
Relapses of idiopathic inflammatory myopathies after vaccination against COVID19: a real-life Italian study 138
Donor-Recipient Mismatch in Lung Transplantation: The Role of Graft Sizing in Clinical Outcomes 135
Lung transplantation in patients with previous or unknown oncological disease: evaluation of short- and long-term outcomes 133
Pulse oximetry oxyhemoglobin saturation in patients with idiopathic pulmonary fibrosis 132
null 121
Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP 120
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review 119
Nintedanib in Idiopathic Pulmonary Fibrosis: a single-centre real-life experience 114
Objective Effects and Patient Preferences for Ambulatory Oxygen in Fibrotic Interstitial Lung Disease With Isolated Exertional Hypoxaemia: A Placebo‐Controlled 6‐Minute Walk Test Study 112
NK and T cell in patients with end-stage lung disorders waiting for lung transplantation in response to CMV infection 112
NK and T cells responses to CMV in patients awaiting for lung transplantation 109
Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity 107
null 106
Calgranulin B/S100A9 and KL-6 in bronchoalveolar lavage of patients with IPF and NSIP 105
Erratum: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis (Respiratory Research (2020) 21 (6) DOI: 10.1186/s12931-019-1263-z) 91
A novel web-based tool for lung transplant patients undergoing extracorporeal photopheresis 87
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica. 58
Totale 21.990
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.776
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.137 0 153 86 97 71 47 57 72 50 118 146 240
2022/20231.799 145 187 195 225 152 266 157 151 154 74 57 36
2023/20241.752 76 49 179 89 80 408 532 67 15 48 51 158
2024/20253.150 108 161 417 152 371 198 169 164 199 139 355 717
2025/20268.668 553 993 1.186 1.053 1.687 304 1.007 243 269 507 275 591
2026/2027556 360 196 0 0 0 0 0 0 0 0 0 0
Totale 22.193